Fisher & Paykel HealthcareASX:FPH +0.13%86 Interest Coverage is 53.02 as of Mar. 2026, which is 1% above its 10-year median of 52.68. GuruFocus rates ASX:FPH with a GF Score™ of 86/100 and a GF Value™ of A$36.31 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 468 Medical Devices & Instruments companies, Fisher & Paykel Healthcare ranks better than 66.03% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Fisher & Paykel Healthcare's
Operating Income
for the
six
months ended in Mar. 2026 was A$212 Mil. Fisher & Paykel Healthcare's Interest Expense for the
six
months ended in Mar. 2026 was A$-4 Mil.
Fisher & Paykel Healthcare's interest coverage for the quarter that ended in Mar. 2026 was 53.02.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Fisher & Paykel Healthcare's Interest Coverage or its related term are showing as below:
ASX:FPH'
s Interest Coverage Range Over the Past 10 Years
Min: 13.98 Med: 52.68 Max: 120.86
Current: 46.39
ASX:FPH's Interest Coverage is ranked better than 66.03% of 468
companies
in the Medical Devices & Instruments industry
Industry Median: 15.71
vs ASX:FPH: 46.39
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Fisher & Paykel Healthcare Interest Coverage Related Terms
Fisher & Paykel Healthcare Interest Coverage Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
ASX:FPH vs ISRG, BDX, MDLN: Interest Coverage Comparison
For the Medical Instruments & Supplies subindustry, Fisher & Paykel Healthcare's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fisher & Paykel Healthcare Interest Coverage vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Fisher & Paykel Healthcare's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Fisher & Paykel Healthcare's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fisher & Paykel Healthcare (ASX:FPH) has a Interest Coverage of 53.02 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Fisher & Paykel Healthcare and its competitors. This is near median its historical median of 52.68. Over the past decade, Fisher & Paykel Healthcare's Interest Coverage has ranged from 13.98 to 120.86. According to the industry distribution chart, Fisher & Paykel Healthcare ranks #159 out of 468 companies in the Medical Devices & Instruments industry, placing it in the top 34%.
Is Fisher & Paykel Healthcare's Interest Coverage too high?
Fisher & Paykel Healthcare's current Interest Coverage of 53.02 is near median its 10-year median of 52.68. Over the past 10 years, this metric has ranged from a low of 13.98 to a high of 120.86. The Medical Devices & Instruments industry median Interest Coverage is 15.71. Fisher & Paykel Healthcare's value of 53.02 is 237.5% above this industry median. Based on the distribution chart, Fisher & Paykel Healthcare ranks #159 out of 468 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Fisher & Paykel Healthcare has a GF Score™ of 86/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Fisher & Paykel Healthcare's Interest Coverage compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Fisher & Paykel Healthcare ranks #159 out of 468 companies for Interest Coverage. This puts Fisher & Paykel Healthcare in the upper half of its industry. The industry median Interest Coverage is 15.71. Fisher & Paykel Healthcare's value of 53.02 is 237.5% above this benchmark. Historically, Fisher & Paykel Healthcare's own Interest Coverage has ranged from 13.98 to 120.86 over the past decade. While the company's 10-year median is 52.68 vs. the industry median of 15.71, Fisher & Paykel Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Devices & Instruments company?
The median Interest Coverage among Medical Devices & Instruments companies is 15.71, based on 468 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fisher & Paykel Healthcare's current Interest Coverage of 53.02 is 237.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Fisher & Paykel Healthcare and its competitors. For the Medical Devices & Instruments industry, the median Interest Coverage is 15.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fisher & Paykel Healthcare's current Interest Coverage is 53.02, which is near median its own 10-year median of 52.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fisher & Paykel Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Fisher & Paykel Healthcare (ASX:FPH) is currently considered Modestly Undervalued. The stock's GF Value™ is A$36.31, compared to a current price of A$31.57 — trading 13.1% below its estimated fair value. The current Interest Coverage is 53.02, which is near median its 10-year median of 52.68 and 237.5% above the Medical Devices & Instruments industry median of 15.71. Fisher & Paykel Healthcare's overall GF Score™ is 86/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Fisher & Paykel Healthcare (ASX:FPH), the current Interest Coverage is 53.02 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fisher & Paykel Healthcare (ASX:FPH) Overvalued in 2026?
Based on GuruFocus' analysis, Fisher & Paykel Healthcare stock appears to be undervalued.
The current stock price of A$31.57 is trading 13.1% below its estimated GF Value™ of A$36.31.
GuruFocus considers Fisher & Paykel Healthcare to be Modestly Undervalued.
Key valuation signals for ASX:FPH:
Interest Coverage: 53.02 (near median its 10-year median of 52.68)
GF Value™: A$36.31 vs. price of A$31.57 (13.1% below fair value)
Industry Position: 237.5% above the Medical Devices & Instruments median (#159 of 468)
No single metric tells the full story. See the ASX:FPH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fisher & Paykel Healthcare is one of the three largest respiratory care device companies globally. It is the market leader in hospital use of humidifiers, masks, and related consumables, and the number three player in the at-home treatment of sleep apnea using respiratory devices. Both the hospital and homecare markets for respiratory devices are growing strongly in the developed markets in which Fisher & Paykel has a presence. The company earns roughly half of its revenue in North America, around a quarter in Europe, and approximately a fifth in Asia-Pacific. Fisher conducts its own R&D and has thousands of patents and pending applications. It manufactures in New Zealand, Mexico, and China, and has a multichannel distribution model.
86GF Score
Get the complete analysis for ASX:FPH
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:FPH has been successfully added to your 
